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INTRODUCTION
Chronic pancreatitis is a serious inflammatory disease of 
varying etiology characterized by parenchymal destruction 
and a change in ductal structure.1 Pancreatic duct stones 
(PDSs) develop during the natural course of chronic pancre-
atitis and are observed in 90% of patients.2 Ductal obstruc-
tion by PDSs causes increased intraductal pressure and isch-
emia from increased parenchymal pressure causes pain.3 
Therefore, treatment of PDSs is necessary in chronic pancre-
atitis to alleviate pain and improve pancreatic function by re-
storing pancreatic duct flow.4,5
PDSs can be managed with endoscopic therapy, surgical 
removal, and extracorporeal shock wave lithotripsy (ESWL).6 
A variety of treatment modalities have been described in 
clinical research of PDSs, although lingering controversies 
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have hindered a consensus recommendation. This review fo-
cuses on endoscopic management of PDSs in chronic pan-
creatitis.
 
HISTORY
Surgery has been the mainstay of PDS treatment, dating to 
the first reported operation by Haggard and Kirtley7 in 1883. 
A hundred years later, advances in medical technology led to 
the introduction of nonsurgical treatment methods. In 1983, 
Inui et al.8 introduced pancreatic sphincterotomy to success-
fully remove PDSs with a basket and in 1985 Fuji et al.9 re-
ported that a pancreatic duct stent could be deployed after 
PDS removal to facilitate pancreatic drainage. In 1987, Sau-
erbruch et al.10,11 reported the successful endoscopic removal 
of PDSs using ESWL, which delivers an extracorporeal shock 
wave to disintegrate the stones. These modalities have since 
been studied in various clinical settings. 
DIAGNOSIS
Although diffuse pancreatic calcification is a characteristic 
of chronic pancreatitis, focal calcification can also be ob-
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served in islet cell tumors and peripancreatic vascular calcifi-
cation. Plain abdominal films can identify calcification in 
only 30% of patients with chronic pancreatitis and cannot be 
used to easily differentiate between ductal calculi and paren-
chymal calcification.12 When pancreatic stones cause duct 
obstruction, an obstructive hydrostatic effect will dilate the 
pancreatic duct, which can assist in the diagnosis of the main 
duct stone. Ultrasonography is useful in detecting the dilated 
pancreatic duct and PDSs, but the head of pancreas may not 
be visualized clearly due to overlying bowel gas or body habi-
tus.13 Computed tomography can better detect pancreatic 
calcification and is helpful when pseudocyst or pancreatic 
parenchymal pathology is suspected.14 Endoscopic retro-
grade cholangiopancreatography (ERCP) and magnetic reso-
nance cholangiopancreatography (MRCP) can be used to vi-
sualize pancreatic duct morphology and identify pseudocysts 
or duct anomalies. Endoscopic ultrasound is a noninvasive 
procedure distinct from ERCP, recently adopted widely be-
cause it can provide information on the ductal system and 
the sizes and positions of stones.15
INDICATIONS FOR TREATMENT
In patients with chronic pancreatitis, medical treatment is 
effective for only 31% of patients but long-term, endoscopic 
treatment is effective for 50% of patients.16 However, selec-
tion of the proper candidate is crucial because endoscopic 
treatment cannot be used for all patients. Liu et al.17 reported 
that the indications for endoscopic treatment were ≤3 non-
compacted stones and PDS diameter ≤10 mm located at the 
pancreatic head or body. If a PDS is situated at the main pan-
creatic duct and is small, removal is more likely to be suc-
cessful.18,19 In contrast, PDSs scattered throughout the pan-
creatic duct or stones at the side branch duct are difficult to 
manage with endoscopy.20,21
The indications for ESWL are broader than other endo-
scopic modalities because it can fractionate large and hard 
PDSs into millimeter sizes. Thus, endoscopic therapy, com-
bined with ESWL, can remove stones in the main duct, as 
well as those in the accessory pancreatic duct.22-25 The Euro-
pean Society of Gastrointestinal Endoscopy (ESGE) recom-
mends ESWL as a first step in treating patients with radi-
opaque PDSs ≥5 mm in the main pancreatic duct, immedia-
tely followed by endoscopic extraction of stone fragments, 
depending on the expertise of the center.26 ESWL can be per-
formed without pancreatic sphincterotomy or ERCP when 
the shape of pancreatic duct is confirmed via MRCP. In these 
cases, even in the absence of pain, it is helpful to preserve 
pancreatic function if it is not accompanied by parenchymal 
atrophy. However, ESWL is contraindicated in pregnancy, 
patients with a tendency to bleed easily, and those with a 
pacemaker, defibrillator, or abdominal aortic aneurysm.27 
Surgery is indicated for patients who do not meet these indi-
cations or for whom nonsurgical treatment has failed.
 
TECHNIQUES FOR STONE REMOVAL
Endoscopic techniques for stone removal include pancre-
atic sphincterotomy; stone retrieval using balloons, baskets, 
or rat tooth forceps; stent placement; mechanical lithotripsy; 
and endoscopic balloon dilation of the pancreatic orifice af-
ter sphincterotomy.28 Approximately 50% of PDSs can be re-
moved by endoscopic sphincterotomy and stone retrieval,29 
while ESWL can fragment large stones to lessen the burden; 
therefore, the addition of ESWL can increase the success rate 
to 60% to 90%.
DIFFICULTY TREATING PANCREATIC 
CALCULI
Endoscopic removal of PDSs can be difficult due to there 
being many stones, their hardness and the impacting nature 
underlying duct stricture.18,29 Moreover, the complication 
rate of pancreatic mechanical lithotripsy is 3-fold higher than 
biliary mechanical lithotripsy.30 Most complications result 
from trapped or broken baskets due to hard stones, although 
acute pancreatitis or pancreatic duct disruption can occur.30 
A tight stricture is found in most patients and there is a risk 
of possible damage to the surrounding pancreatic parenchy-
ma during treatment.
 
ENDOSCOPIC PANCREATIC 
SPHINCTEROTOMY AND BALLOON 
SPHINCTEROPLASTY
To remove symptomatic, but not spontaneously passing 
PDSs, pancreatic sphincterotomy can be performed on ma-
jor or minor papilla. Pancreatic sphincterotomy can be per-
formed with a pull-type sphincter tome over a guide wire or 
with a needle-knife incision. The risks of pancreatic sphinc-
terotomy are similar to that of biliary sphincterotomy and 
include acute pancreatitis (2% to 7%), bleeding (0% to 2%), 
and perforations (<1%) as early complications and sphincter 
stenosis (up to 10%) as a late complication.31-33 Moreover, a 
case report in a tropical area reported the application of en-
doscopic balloon dilation after pancreatic sphincterotomy 
for the removal of a large radiolucent stone without stricture 
in the main pancreatic duct.28
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EXTRACTION BALLOONS, BASKETS, 
AND FORCEPS
Baskets, balloons, and forceps are used to remove stones 
by capturing or sweeping them from the pancreatic duct 
through the small intestinal lumen. The basket is opened 
within the duct, to capture the stone and pull it into the small 
intestinal lumen or the stone may be fragmented by mechan-
ical lithotripsy (Fig. 1). When the PDS diameter is ≤5 mm, 
standard biliary baskets are less effective than pancreatic 
stone baskets. Furthermore, it is difficult to capture a ≤6 mm 
stone within the duct and the complication rate is higher 
than that of a balloon.30 Although rare, if the downstream 
duct is smaller than the stone, an extraction basket may be-
come trapped within the pancreatic duct.34 In contrast, ex-
traction balloons can be deflated within the duct to minimize 
the risk of trapping. Thus, PDS removal using an extraction 
balloon during ERCP is safer with a comparatively low com-
plication rate.35 However, the balloon can be punctured by 
the edge of stone. Rat tooth forceps can be used to capture 
stones 1 to 2 cm distal of the main duct and are relatively saf-
er to use than a basket, although inserting forceps into the 
pancreatic duct is technically difficult and pancreatic duct 
trauma is of concern.36
STONE FRAGMENTATION USING ESWL
ESWL can fragment PDSs, which consist of calcium car-
bonate over a protein matrix.37 The size, an obstacle of endo-
scopic therapy, can be overcome with stone fragmentation by 
ESWL (Fig. 2).12,17,38 ESWL is safe, effective, and noninvasive 
because broken pieces can be removed spontaneously out of 
the pancreatic duct once they are reduced in size. Therefore, 
ESWL can be used as a primary treatment, in addition to its 
compensatory role in endoscopic therapy.25,38-40 In a meta-
analysis of ESWL, a 37% to 100% clearance rate was noted in 
491 patients, and effective pain control occurred spontane-
ously,41 while in another review involving 1,100 patients, 89% 
demonstrated successful fragmentation.42 In patients who 
underwent ESWL, long-term follow-up revealed that 85% of 
patients felt less pain, 50% became completely pain-free 
without the use of narcotics and 84% avoided surgical inter-
vention.43 Differences in complete removal rates could be ex-
plained by selection criteria, method of preprocedural assess-
ment, ESWL technique and device, ERCP technique and 
timing, and lack of uniform criteria to determine final out-
come.
In a randomized study that compared ESWL alone (n=26) 
to ESWL with endoscopic therapy (n=29), ESWL alone was 
A  
C  
B  
D  
Fig. 1. Endoscopic intervention for pancreatic duct stones (PDSs). (A) Abdominal computed tomographic scan shows a 4 mm sized calci-
fied stone (white arrow) in pancreatic head within dilated pancreatic duct. (B) Small size of the PDSs let basket removal possible (black ar-
row). (C) PDS was visualized intraluminally. (D) No filling defect was observed in the main pancreatic duct after complete stone removal. 
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safer and more effective.40 Long-term follow-up of patients 
with ESWL with endoscopic therapy determined that pain 
was alleviated and surgery was avoided in two-thirds of the 
cases.14 Thus, ESWL can assist in long-term pain relief, when 
it is combined with endoscopic therapy to treat PDSs under 
the proper indications. Complications of ESWL include con-
tusions on the skin or duodenum, mild abdominal discom-
fort, exacerbation of pancreatitis, and asymptomatic hyper-
amylasemia. The rate of acute pancreatitis is 6.3% to 12.5%24,44 
and severe complications, such as death, occur in <1% of pa-
tients45 when PDSs in chronic pancreatitis are treated with 
ESWL alone. It is generally recommended that a pancreatic 
stent be temporarily inserted during ERCP as a bridge treat-
ment to facilitate drainage and lower the risk of post-ERCP 
pancreatitis.46 When performing ESWL, epidural anesthesia 
is effective45 and in cases with a radiolucent stone, which can 
be difficult to target under fluoroscopy, contrast can be in-
jected using an endoscopic nasopancreatic drainage catheter 
or ultrasound-guided shock wave lithotripsy. 
 
INTRADUCTAL MECHANICAL 
LITHOTRIPSY AND ELECTRO 
HYDRAULIC LITHOTRIPSY
Large stones can be removed through papilla with ease 
when ground into small pieces by mechanical lithotripsy, 
ESWL, or intraductal electrohydraulic lithotripsy (EHL). 
Mechanical lithotripsy is accompanied by higher risk of fail-
ure and complication; hence, it is performed less frequently 
than biliary stone lithotripsy.47 There are a limited number of 
studies on intraductal EHL for PDS fragmentation.48 EHL is 
performed under direct vision via a mother-daughter scope 
A  
C  
B  
D  
Fig. 2. Endoscopic intervention after extracorporeal shock wave lithotripsy (ESWL) for fragmentation of large stone. (A) Abdominal comput-
ed tomographic scan shows 10 mm sized calcified stones (white arrow) in pancreatic head within markedly dilated pancreatic duct. (B) 
Large pancreatic duct stones in the pancreas head (black arrow) rendered the catheter impassable. (C) After two sessions of ESWL, stones 
were fragmented to the degree that can be removed with basket. (D) No filling defect was observed in the main pancreatic duct after com-
plete stone removal.
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system using a pancreatoscope or spyscope and can deliver 
high energy to the stone. The process can directly injure the 
ductal wall and has limitations when a small endoscope-ob-
structing stricture is present.49 In addition, the technique is 
technically demanding and requires expensive equipment. 
Therefore, it is considered a second-line treatment after 
ESWL has failed due to its technically demanding nature and 
the equipment required.26
SHORT-TERM AND LONG-TERM 
OUTCOMES
The symptom relief rate of endoscopic therapy in PDSs is 
77% to 100% in the short term and 54% to 86% in the long 
term.14,36,50 Similarly, that of ESWL is 70%.51 In a previous 
study,52 patients with stones >5 mm who did not receive 
standard endoscopic therapy were followed up after ESWL. 
Intermediate-term (24 to 60 months) and long-term (>60 
months) follow-up demonstrated that pain was well con-
trolled with a low recurrence rate. Long-term outcomes after 
endoscopic treatment are summarized in Table 1.38,43,50,52-56
 
BENEFIT TO PANCREAS FUNCTION
There is a controversy over whether PDS removal by 
ESWL and endoscopic treatment can preserve exocrine 
function. A study by Adamek et al.19 revealed that endoscop-
ic therapy and ESWL management did not prevent or delay 
glandular insufficiency, while Inui et al.53 reported that 38% 
showed improvement in exocrine function, although this 
was not significant due to a small sample size. Tandan et al.52 
also reported that exocrine and endocrine dysfunction dem-
onstrated some improvement. In addition, a study using se-
cretin-enhanced MRCP (S-MRCP) demonstrated that pan-
creatic exocrine function improved after endoscopic inter-
vention. In chronic pancreatitis patients, pancreatic flow out-
put and total excreted volume were measured after endoscopic 
treatment by S-MRCP. Before the procedure, the values were 
3.5 mL/min and 42 mL, respectively. After the procedure, the 
values were significantly higher, at 5.6 and 72 mL/min, re-
spectively.52 Therefore, an adequately designed study of exo-
crine function is necessary. 
 
COMPARISON WITH SURGICAL 
TREATMENT
In two prospective randomized comparative studies that 
compared clinical outcomes of endoscopic and surgical 
treatment for PDSs, surgery was more effective than endo-
scopic therapy.57-59 Díte et al.57 reported that complete or par- Ta
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tial pain relief was achieved in 61% of patients who under-
went endoscopic treatment, compared to 86% of patients 
who underwent surgical treatment (p=0.002). Cahen et al.58 
reported that complete or partial pain relief was achieved in 
32% of the endoscopic treatment group compared to 75% of 
the surgical treatment group (p=0.007) (Table 2). Although 
the duration and frequency of hospitalizations, and medical 
costs were similar in the short-term endoscopic treatment 
and surgery groups, patients in the long-term endoscopic 
treatment group were hospitalized longer, which resulted in 
higher medical costs than patients who received short-term 
endoscopic treatment and surgical treatment.60 In another 
study, as modified Puestow procedure was effective for pain 
relief after 37 months of follow-up and was relatively safe 
with a 5.7% complication rate.17 Additional drainage was 
necessary in 68% of patients who underwent endoscopic in-
tervention, which was higher than the 5% reported in the 
surgery group. Furthermore, 47% of patients in the endo-
scopic group received an additional salvage operation that 
was not effective. Nonetheless, endoscopic treatment was 
preferred because it is less invasive and surgical treatment 
could be performed after treatment failure. Thus, endoscopic 
therapy can delay or obviate the need for an operation.57,58 
Therefore, despite the superiority of surgery for pain man-
agement, endoscopic intervention is necessary as a bridging 
therapy.
 
NECESSITY OF SURGERY
The aim of surgery is to remove PDSs causing pancreatic 
duct obstruction and preserve pancreatic function by de-
compressing the pancreatic duct. The decision to undergo 
surgery can be made based on many factors, such as the di-
ameter of the main duct, the presence of stricture, an accom-
panying pseudocyst, the presence of a mass with the possibil-
ity of cancer, duodenal or biliary obstruction, the position of 
the stone, the severity of disease, and one’s overall condition 
(Fig. 3). Thus, surgery is the treatment of choice when endo-
scopic treatment has failed, malignancy is suspected, and/or 
duodenal stricture is present. The presence of a main PDS 
without duct stricture can be successfully managed with en-
doscopy or ESWL. Instead of performing endoscopic or sur-
gical management, many factors should be considered and 
surgery should be performed when endoscopy has failed.
CURRENT GUIDELINES 
The current American Society for Gastrointestinal Endos-
copy (ASGE) and ESGE guidelines for treatment of chronic 
pancreatitis are useful for the treatment of PDSs.26,61 Al- Ta
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though surgical treatment would provide a better outcome, 
the ASGE suggests endoscopic therapy as the first-line treat-
ment because of its lower degree of invasiveness and recom-
mends several rounds of ESWL for stone fragmentation, as 
necessary.61 Unlike the ASGE, the ESGE guideline recom-
mends ESWL as the first treatment step, especially when 
PDSs are >5 mm. For fewer stones that are <5 mm and locat-
ed between the pancreatic head and body, the ESGE recom-
mends endoscopy.26 Both of these guidelines recommend 
endoscopic treatment as the first-line treatment for such 
stones, rather than surgery, but the ESGE guideline empha-
sizes the role of ESWL more than the ASGE guideline.
CONCLUSIONS
For the treatment of pancreatic calculi, a nonsurgical 
method such as endoscopic therapy in combination with 
ESWL is as effective as a surgical method. Several compara-
tive studies have reported the superiority of surgery in terms 
of the duration and frequency of hospitalizations, cost, pain 
relief, and reintervention. However, in patients with the ap-
propriate indications or who are at high risk for surgery, en-
doscopic therapy in combination with ESWL can be consid-
ered a first-line treatment. We expect that the development 
of advanced endoscopic techniques and equipment will ex-
pand the role of endoscopic treatment in PDS removal.
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